Publications
359
Citations
37,094
Est. group size
~2
Recurring co-author estimate
Active years
39
Publishing since 1988
Avirup Guha works in cardio-oncology, a field that studies how cancer treatments affect heart and blood vessel health, and how cardiovascular disease and cancer intersect. Their work spans immune checkpoint inhibitor and chemotherapy-related heart complications, cardiovascular risk prediction in cancer patients, machine learning-based risk scoring, and large-scale global burden of disease studies on heart disease, obesity, and mortality. Research also touches on health disparities, such as racial and socioeconomic differences in cardiovascular outcomes among cancer patients.
Publication output has grown substantially over the last decade, rising from about 11 papers per year in 2017 to over 60 in 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Global, regional and national burden of ischemic heart disease attributable to suboptimal diet, 1990–2023: a Global Burden of Disease study
Nature Medicine · 2026
- Racial disparity in microvascular function among non‐Hispanic white and non‐Hispanic black men with newly diagnosed prostate cancer
Physiological Reports · 2026
- Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association
Journal of Clinical Oncology · 2026
- Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association
Circulation · 2026
- Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
The Lancet · 2025
- Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
The Lancet · 2025
- Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023
The Lancet · 2025
- Immune checkpoint inhibitor-associated myocarditis: a novel risk score
European Heart Journal · 2025
- Cancer and Cardiovascular Disease
JACC CardioOncology · 2025
- AI-driven prediction of cardio-oncology biomarkers through protein corona analysis
Chemical Engineering Journal · 2025
- Myocarditis‐Associated Cardiogenic Shock: A Nationwide Multicenter Study
Journal of the American Heart Association · 2025
- A novel machine learning-based cancer-specific cardiovascular disease risk score among patients with breast, colorectal, or lung cancer
JNCI Cancer Spectrum · 2025
- Statin Use in Patients With Advanced Prostate Cancer in the TITAN and SPARTAN Trials
JAMA Network Open · 2025
- Multiscale profiling of tyrosine kinase inhibitor cardiotoxicity reveals mechanosensitive ion channel PIEZO1 as cardioprotective
Science Translational Medicine · 2025
- Cardiotoxic Effects of Antibody Drug Conjugates vs Standard Chemotherapy in <i>ERBB2</i> -Positive Advanced Breast Cancer
JAMA Network Open · 2025
- Circulation×54
- Journal of the American College of Cardiology×25
- JACC CardioOncology×15
- The Lancet×14
- Journal of the American Heart Association×13
- Daniel Addison
Medicine · The Ohio State University
- Yu Kang
Medicine · The Ohio State University
- Adnan Shaaban
Medicine · The Ohio State University
- Adam S. Potter
Medicine · The Ohio State University
- Somayya J. Mohammad
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile